CorVel Corp. 10-Q Summary: Quarter Ended December 31, 1996
Business Context and Reporting Period
CorVel Corporation (Delaware) filed a Form 10-Q for the quarter ended December 31, 1996. The company operates in the workers' compensation managed care industry, providing medical case management, vocational rehabilitation, and provider program services. As of December 31, 1996, there were 4,593,354 shares of Common Stock outstanding.
Key Financial Metrics
| Metric | Three Months Ended Dec 31, 1996 | Nine Months Ended Dec 31, 1996 |
|---|---|---|
| Revenues | $30,441,000 | $90,011,000 |
| Net Income | $2,177,000 | $6,311,000 |
| Diluted EPS | $0.46 | $1.33 |
| Gross Margin | 18.6% | 18.4% |
| Operating Margin | 11.5% | 11.3% |
| Net Cash from Operations | N/A (Quarterly not provided) | $12,107,000 |
| Cash and Equivalents | $23,077,000 (Balance Sheet) | $23,077,000 (Balance Sheet) |
| Total Debt | $0 | $0 |
Note: The filing does not explicitly list long-term debt; total liabilities consist of current liabilities and deferred income taxes.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 12% year-over-year for the quarter ($3.4M increase) and 11% for the nine-month period ($9.3M increase). Growth was driven by a 14% increase in patient management revenues and a 10% increase in provider program revenues for the quarter.
- Profitability: Net income rose 15% for the quarter and 17% for the nine-month period compared to the prior year.
- Expense Management: General and administrative expenses as a percentage of revenue declined from 7.5% to 7.1% for both the quarter and nine-month periods, despite a nominal increase in absolute expense dollars.
- Liquidity: Net working capital increased by $4.1 million to $34.8 million. Cash and cash equivalents grew from $17.1 million to $23.1 million.
- Stock Repurchases: The company repurchased 78,000 shares for $2.1 million during the quarter. Cumulative repurchases since the program's approval totaled 314,000 shares for $8.3 million.
Outlook, Risks, and Management Commentary
Management Commentary: Management noted that revenue growth was lower than in previous years, partially attributable to a reduction in the national growth rate of healthcare expenditures. However, growth in PPO revenues (higher margin) offset pricing pressure in patient management.
Guidance: The filing does not provide specific numerical guidance for future periods. Management believes current cash balances and internally generated funds are sufficient for the next twelve months.
Risks and Contingencies:
- Regulatory Changes: Potential adverse impact from state licensing requirements for medical review services and evolving managed care regulations.
- Legislative Reform: Proposals to combine workers' compensation with traditional health plans (24-hour coverage) could reduce demand for CorVel's services.
- Competition: Intensifying competition from HMOs, PPOs, and large insurers entering the workers' compensation market.
- Legal Liability: Risk of litigation regarding medical treatment recommendations, though the company maintains professional liability insurance.
- Market Dynamics: Declines in workers' compensation claims and costs in certain states could adversely affect business volume.
Investor Verification Checklist
- Verify the sustainability of the 11-12% revenue growth rate given the noted slowdown in national healthcare expenditure growth.
- Confirm the status of state-specific licensing requirements and any pending regulatory actions that could increase operating costs.
- Assess the impact of legislative proposals to integrate workers' compensation into standard health plans on future revenue streams.
- Review the details of the stock repurchase program and remaining authorization (350,000 shares authorized; 314,000 repurchased as of Feb 1997).
- Monitor the company's ability to maintain gross margins as it expands into the more competitive group health market.